{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:52:52Z","timestamp":1787025172788,"version":"build-2736575974"},"reference-count":47,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AO"],"abstract":"<jats:p>Background: Assessment of cardiac disease before cancer therapy is crucial, as advancements in cancer treatment have led to prolonged survival and an increase in cardiovascular complications. Specifically, esophageal cancer and heart disease share common risk factors, such as smoking and obesity. Radiation therapy (RT) for esophageal cancer is associated with elevated cardiac radiation exposure. This study aimed to assess the prevalence of coronary artery disease (CAD) in patients with esophageal cancer who were eligible for RT.\nMethods: We examined the prevalence of coronary artery stenosis, abnormal myocardial perfusion, and late enhancement using pre-RT cardiac computed tomography (CT) data of 41 patients with thoracic esophageal cancer who were referred for RT between January 2017 and June 2023 and had no history of ischemic heart disease.\nResults: The median age of the 41 patients was 71 years, with 40 patients being male. Cardiac CT identified significant coronary stenosis (\u226550% luminal narrowing) in 18 patients (44%), among whom 9 (50%) had severe stenosis, multivessel disease, or myocardial ischemia. Significant stenosis was most frequently observed in the left anterior descending artery (16\/18). Late enhancement, indicating myocardial infarction, was observed in seven patients (17%).\nInterpretation: Patients with esophageal cancer without a history of ischemic heart disease had a high prevalence (44%) of CAD, with half of them having severe stenosis, multivessel disease, or myocardial ischemia. Given the high prevalence of coronary stenosis, pre-treatment cardiac evaluation is crucial for patients with esophageal cancer. Incorporating cardiac CT findings into radiotherapy planning is recommended to optimize patient care.<\/jats:p>","DOI":"10.2340\/1651-226x.2025.42563","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T08:12:17Z","timestamp":1738570337000},"page":"200-207","source":"Crossref","is-referenced-by-count":3,"title":["Cardiac CT reveals high prevalence of coronary artery disease in esophageal cancer eligible for radiotherapy"],"prefix":"10.2340","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1944-2971","authenticated-orcid":false,"given":"Akinori","family":"Takada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Toyomasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamitsu","family":"Mase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Nomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kakuya","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"97461","doi-asserted-by":"crossref","unstructured":"Wang J, Wei C, Tucker SL, Myles B, Palmer M, Hofstetter WL, et al. Predictors of postoperative complications after trimodality therapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2013;86(5):885\u201391.","DOI":"10.1016\/j.ijrobp.2013.04.006"},{"key":"97462","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ijrobp.2013.04.006","DOI":"10.1016\/j.ijrobp.2013.04.006"},{"key":"97463","doi-asserted-by":"crossref","unstructured":"Lin SH, Zhang N, Godby J, Wang J, Marsh GD, Liao Z, et al. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. Cancer. 2016;122(6):917\u201328.","DOI":"10.1002\/cncr.29857"},{"key":"97464","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/cncr.29857","DOI":"10.1002\/cncr.29857"},{"key":"97465","doi-asserted-by":"crossref","unstructured":"Lin SH, Wang L, Myles B, Thall PF, Hofstetter WL, Swisher SG, et al. Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2012;84(5):1078\u201385.","DOI":"10.1016\/j.ijrobp.2012.02.015"},{"key":"97466","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ijrobp.2012.02.015","DOI":"10.1016\/j.ijrobp.2012.02.015"},{"key":"97467","doi-asserted-by":"crossref","unstructured":"He L, Chapple A, Liao Z, Komaki R, Thall PF, Lin SH. Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer. Radiother Oncol. 2016;121(1):70\u20134.","DOI":"10.1016\/j.radonc.2016.08.005"},{"key":"97468","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2016.08.005","DOI":"10.1016\/j.radonc.2016.08.005"},{"key":"97469","doi-asserted-by":"crossref","unstructured":"Xi M, Xu C, Liao Z, Chang JY, Gomez DR, Jeter M, et al. Comparative outcomes after definitive chemoradiotherapy using proton beam therapy versus intensity modulated radiation therapy for esophageal cancer: a retrospective, single-institutional analysis. Int J Radiat Oncol Biol Phys. 2017;99(3):667\u201376.","DOI":"10.1016\/j.ijrobp.2017.06.2450"},{"key":"97470","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.06.2450","DOI":"10.1016\/j.ijrobp.2017.06.2450"},{"key":"97471","doi-asserted-by":"crossref","unstructured":"Wang X, Palaskas NL, Yusuf SW, Abe JI, Lopez-Mattei J, Banchs J, et al. Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer. J Thorac Oncol. 2020;15(10):1682\u201390.","DOI":"10.1016\/j.jtho.2020.06.014"},{"key":"97472","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jtho.2020.06.014","DOI":"10.1016\/j.jtho.2020.06.014"},{"key":"97473","doi-asserted-by":"crossref","unstructured":"van den Bogaard VA, Ta BD, van der Schaaf A, Bouma AB, Middag AM, Bantema-Joppe EJ, et al. Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures. J Clin Oncol. 2017;35(11):1171\u20138.","DOI":"10.1200\/JCO.2016.69.8480"},{"key":"97474","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1200\/JCO.2016.69.8480","DOI":"10.1200\/JCO.2016.69.8480"},{"key":"97475","doi-asserted-by":"crossref","unstructured":"Banfill K, Giuliani M, Aznar M, Franks K, McWilliam A, Schmitt M, et al. Cardiac toxicity of thoracic radiotherapy: existing evidence and future directions. J Thorac Oncol. 2021;16(2):216\u201327.","DOI":"10.1016\/j.jtho.2020.11.002"},{"key":"97476","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jtho.2020.11.002","DOI":"10.1016\/j.jtho.2020.11.002"},{"key":"97477","unstructured":"Frandsen J, Boothe D, Gaffney DK, Wilson BD, Lloyd S. Increased risk of death due to heart disease after radiotherapy for esophageal cancer. J Gastrointest Oncol. 2015;6(5):516\u201323."},{"key":"97478","doi-asserted-by":"crossref","unstructured":"Pao TH, Chang WL, Chiang NJ, Lin CY, Lai WW, Tseng YL, et al. Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer. Radiat Oncol. 2020;15(1):48.","DOI":"10.1186\/s13014-020-01498-3"},{"key":"97479","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s13014-020-01498-3","DOI":"10.1186\/s13014-020-01498-3"},{"key":"97480","doi-asserted-by":"crossref","unstructured":"Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Bronnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987\u201398.","DOI":"10.1056\/NEJMoa1209825"},{"key":"97481","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa1209825","DOI":"10.1056\/NEJMoa1209825"},{"key":"97482","doi-asserted-by":"crossref","unstructured":"Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002;20(5):1167\u201374.","DOI":"10.1200\/JCO.2002.20.5.1167"},{"key":"97483","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1200\/JCO.2002.20.5.1167","DOI":"10.1200\/JCO.2002.20.5.1167"},{"key":"97484","doi-asserted-by":"crossref","unstructured":"Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. Lancet Oncol. 2015;16(2):187\u201399.","DOI":"10.1016\/S1470-2045(14)71207-0"},{"key":"97485","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S1470-2045(14)71207-0","DOI":"10.1016\/S1470-2045(14)71207-0"},{"key":"97486","doi-asserted-by":"crossref","unstructured":"Kamimura D, Cain LR, Mentz RJ, White WB, Blaha MJ, DeFilippis AP, et al. Cigarette smoking and incident heart failure: insights from the Jackson heart study. Circulation. 2018;137(24):2572\u201382.","DOI":"10.1161\/CIRCULATIONAHA.117.031912"},{"key":"97487","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.031912","DOI":"10.1161\/CIRCULATIONAHA.117.031912"},{"key":"97488","doi-asserted-by":"crossref","unstructured":"Guenancia C, Lefebvre A, Cardinale D, Yu AF, Ladoire S, Ghiringhelli F, et al. Obesity as a risk factor for anthracyclines and trastuzumab cardiotoxicity in breast cancer: a systematic review and meta-analysis. J Clin Oncol. 2016;34(26):3157\u201365.","DOI":"10.1200\/JCO.2016.67.4846"},{"key":"97489","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1200\/JCO.2016.67.4846","DOI":"10.1200\/JCO.2016.67.4846"},{"key":"97490","doi-asserted-by":"crossref","unstructured":"Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol. 2003;21(14):2697\u2013702.","DOI":"10.1200\/JCO.2003.03.055"},{"key":"97491","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1200\/JCO.2003.03.055","DOI":"10.1200\/JCO.2003.03.055"},{"key":"97492","doi-asserted-by":"crossref","unstructured":"Morota M, Gomi K, Kozuka T, Chin K, Matsuura M, Oguchi M, et al. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2009;75(1):122\u20138.","DOI":"10.1016\/j.ijrobp.2008.10.075"},{"key":"97493","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.ijrobp.2008.10.075","DOI":"10.1016\/j.ijrobp.2008.10.075"},{"key":"97494","doi-asserted-by":"crossref","unstructured":"Wright CD, Kucharczuk JC, O\u2019Brien SM, Grab JD, Allen MS, Society of Thoracic Surgeons General Thoracic Surgery D. Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model. J Thorac Cardiovasc Surg. 2009;137(3):587\u201395; discussion 96.","DOI":"10.1016\/j.jtcvs.2008.11.042"},{"key":"97495","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jtcvs.2008.11.042","DOI":"10.1016\/j.jtcvs.2008.11.042"},{"key":"97496","doi-asserted-by":"crossref","unstructured":"Takada A, Ichikawa Y, Nakamura S, Toyomasu Y, Kawamura T, Nanpei Y, et al. Preliminary results of reduced myocardial blood flow in the subacute phase after radiation therapy for thoracic esophageal cancer: a quantitative analysis with stress dynamic myocardial computed tomography perfusion imaging. Radiother Oncol. 2022;177:191\u20136.","DOI":"10.1016\/j.radonc.2022.11.002"},{"key":"97497","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.radonc.2022.11.002","DOI":"10.1016\/j.radonc.2022.11.002"},{"key":"97498","doi-asserted-by":"crossref","unstructured":"Bittencourt MS, Hulten E, Polonsky TS, Hoffman U, Nasir K, Abbara S, et al. European Society of cardiology-recommended coronary artery disease consortium pretest probability scores more accurately predict obstructive coronary disease and cardiovascular events than the diamond and forrester score: the partners registry. Circulation. 2016;134(3):201\u201311.","DOI":"10.1161\/CIRCULATIONAHA.116.023396"},{"key":"97499","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.023396","DOI":"10.1161\/CIRCULATIONAHA.116.023396"},{"key":"97500","doi-asserted-by":"crossref","unstructured":"Nazir MS, Murphy T, Poku N, Wheen P, Nowbar AN, Andres MS, et al. Clinical utility and prognostic value of coronary computed tomography angiography in patients with cancer. Am J Cardiol. 2023;207:448\u201354.","DOI":"10.1016\/j.amjcard.2023.08.121"},{"key":"97501","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.amjcard.2023.08.121","DOI":"10.1016\/j.amjcard.2023.08.121"},{"key":"97502","doi-asserted-by":"crossref","unstructured":"Nakamura S, Kitagawa K, Goto Y, Omori T, Kurita T, Yamada A, et al. Incremental prognostic value of myocardial blood flow quantified with stress dynamic computed tomography perfusion imaging. JACC Cardiovasc Imaging. 2019;12(7 Pt 2):1379\u201387.","DOI":"10.1016\/j.jcmg.2018.05.021"},{"key":"97503","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jcmg.2018.05.021","DOI":"10.1016\/j.jcmg.2018.05.021"},{"key":"97504","doi-asserted-by":"crossref","unstructured":"Nakamura S, Kitagawa K, Goto Y, Takafuji M, Nakamori S, Kurita T, et al. Prognostic value of stress dynamic computed tomography perfusion with computed tomography delayed enhancement. JACC Cardiovasc Imaging. 2020;13(8):1721\u201334.","DOI":"10.1016\/j.jcmg.2019.12.017"},{"key":"97505","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jcmg.2019.12.017","DOI":"10.1016\/j.jcmg.2019.12.017"},{"key":"97506","doi-asserted-by":"crossref","unstructured":"Klein LW, Weintraub WS, Agarwal JB, Schneider RM, Seelaus PA, Katz RI, et al. Prognostic significance of severe narrowing of the proximal portion of the left anterior descending coronary artery. American Journal of Cardiology. 1986;58(1):42-6.","DOI":"10.1016\/0002-9149(86)90238-9"},{"key":"97507","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/0002-9149(86)90238-9","DOI":"10.1016\/0002-9149(86)90238-9"}],"container-title":["Acta Oncologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/42563\/48997","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/download\/42563\/48997","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:04:58Z","timestamp":1756404298000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/42563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":47,"URL":"https:\/\/doi.org\/10.2340\/1651-226x.2025.42563","relation":{},"ISSN":["1651-226X"],"issn-type":[{"value":"1651-226X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]}}}